Léčivé přípravky s obsahem účinné látky Romiplostim
Economic Operator with Whom the Contract Has Been Concluded
| Show detail | ||||||||
|---|---|---|---|---|---|---|---|---|
| S2025/00983/00 | 20. 01. 2026 | Amgen s.r.o. | 8 725 942,31 | 7 791 019,92 | 8 725 942,31 | 7 791 019,92 | CZK |
Published Documents
| Show detail | |||||
|---|---|---|---|---|---|
| S2025/00983/00 | S2025_00938_00 Kupní smlouva Romiplostim_anon.pdf | Smlouva | 26. 01. 2026 09:47 | Dokument není zavirovaný |
List of Participants
| Show detail | |||||||
|---|---|---|---|---|---|---|---|
| Amgen s.r.o. | Praha | 8 725 942,31 | 7 791 019,92 | CZK | Yes | Yes |
Written Report - Justification
| Show detail | Justification for using other means of communication for submitting bids instead of electronic means | Justification for not dividing an above-threshold public procurement into lots | Justification for setting requirements for proving turnover in case of proceeding according to Article 78(3), if not stated in the tender documentation |
|---|---|---|---|
| povaha zakázky to neumožňuje | nestanoveno |